You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Aurobindo Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for AUROBINDO, and what generic and branded alternatives to AUROBINDO drugs are available?

AUROBINDO has five hundred and twelve approved drugs.

There are nineteen tentative approvals on AUROBINDO drugs.

Summary for Aurobindo

US Patents:	0
Tradenames:	388
Ingredients:	361
NDAs:	512
Patent Litigation for Aurobindo:	See patent lawsuits for Aurobindo
PTAB Cases with Aurobindo as petitioner:	See PTAB cases with Aurobindo as petitioner

Drugs and US Patents for Aurobindo

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aurobindo Pharma	FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE	fosinopril sodium; hydrochlorothiazide	TABLET;ORAL	079245-002	Jul 9, 2009	AB	RX	No	Yes		⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma	STAVUDINE	stavudine	CAPSULE;ORAL	077672-003	Dec 29, 2008		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Ltd	GALANTAMINE HYDROBROMIDE	galantamine hydrobromide	TABLET;ORAL	090957-003	Mar 29, 2011	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Usa	RASAGILINE MESYLATE	rasagiline mesylate	TABLET;ORAL	201971-001	May 15, 2017	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma	CEFOTAXIME SODIUM	cefotaxime sodium	INJECTABLE;INJECTION	065517-002	Nov 6, 2009		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Ltd	DIGOXIN	digoxin	TABLET;ORAL	214982-002	Feb 8, 2022	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Ltd	LORATADINE	loratadine	SYRUP;ORAL	208931-001	Jun 29, 2018		OTC	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Aurobindo

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Aurobindo Pharma Usa	MAXZIDE	hydrochlorothiazide; triamterene	TABLET;ORAL	019129-001	Oct 22, 1984	4,105,783	⤷ Sign Up
Aurobindo Pharma Usa	MAXZIDE-25	hydrochlorothiazide; triamterene	TABLET;ORAL	019129-003	May 13, 1988	4,444,769	⤷ Sign Up
Aurobindo Pharma Usa	MAXZIDE	hydrochlorothiazide; triamterene	TABLET;ORAL	019129-001	Oct 22, 1984	4,444,769	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for AUROBINDO drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.